? CENTER OVERVIEW In order to rapidly develop effective therapies to prevent or reverse progression of chronic kidney disease (CKD), the University of Michigan O'Brien Kidney Translational Core Center will support the full spectrum of a translational pipeline providing resources to basic and clinical investigators in our Institutional and International Research Bases using a 3-pronged approach: ? Expansion of our unique CKD cohort combined with its longitudinal tissue, urine and serum biobanks to allow our research base investigators to investigate the molecular causes and endpoints of chronic kidney diseases; ? Dissemination and support of the most modern and powerful systems biological approaches for research base investigators to help them effectively identify novel and robust biomarkers, endpoints and targets for diagnosis and treatment of CKD; ? Expert analysis and integration of cohort and systems data for our research base investigators through the use of sophisticated bioinformatics and database integration that promote identification of specific pathways and targets for treatments for individuals or groups of subjects with CKD. The Center's aims are to: 1) Expand translational and systems biological approaches to kidney disease research by expanding the Center's CKD deep clinical phenotyping and biobanking efforts through the Clinical Phenotyping and Resource Biobank Core (C-PROBE); 2) Introduce, stimulate and apply state-of-the-art systems biological approaches to kidney disease research studies by our Institutional Research Core investigators through the use of sophisticated but user-friendly genetic, transcriptomic, proteomic, metabolomic and lipidomic approaches through the Applied Systems Biology Core; 3) Enhance the understanding of complex kidney diseases and the multi-scalar data sets that accompany systems biological approaches to their functional implications regarding kidney disease development, diagnosis, progression and therapeutic potential through the Data Analytic Services Core (DASC); 4) Expand worldwide outreach efforts via Nephroseq and tranSMART; 5) Use the Kidney Educational Enrichment Programs and the Pilot and Feasibility Program to entice trainees and faculty into kidney research and support our research bases in their ongoing kidney research.

Public Health Relevance

Chronic kidney disease (CKD) remains a major health problem that causes substantial disability and premature death. The University of Michigan George M. O'Brien Kidney Translational Core Center will provide researchers the opportunity to utilize advanced technologies by providing the necessary infrastructure and tools to improve care of patients with CKD. Through its research cores, enrichment activities, and pilot and feasibility grant programs, it will enable new discoveries and enhance scientific progress supporting cutting-edge basic, clinical and translational research by its highly interactive research base.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK081943-13
Application #
9985805
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Kimmel, Paul
Project Start
2008-09-01
Project End
2023-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
13
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Mulder, Skander; Hamidi, Habib; Kretzler, Matthias et al. (2018) An integrative systems biology approach for precision medicine in diabetic kidney disease. Diabetes Obes Metab 20 Suppl 3:6-13
Duda, Marlena; Zhang, Hongjiu; Li, Hong-Dong et al. (2018) Brain-specific functional relationship networks inform autism spectrum disorder gene prediction. Transl Psychiatry 8:56
Afshinnia, Farsad; Rajendiran, Thekkelnaycke M; Wernisch, Stefanie et al. (2018) Lipidomics and Biomarker Discovery in Kidney Disease. Semin Nephrol 38:127-141
Jadoon, Adil; Mathew, Anna V; Byun, Jaeman et al. (2018) Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients. Am J Nephrol 48:269-277
Mathew, Anna V; Li, Lei; Byun, Jaeman et al. (2018) Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 41:2431-2437
Skorecki, Karl L; Lee, Jessica H; Langefeld, Carl D et al. (2018) A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy. Nephrol Dial Transplant 33:323-330
Heinzel, Andreas; Kammer, Michael; Mayer, Gert et al. (2018) Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes. Diabetes Care 41:1947-1954
Wernisch, Stefanie; Afshinnia, Farsad; Rajendiran, Thekkelnaycke et al. (2018) Probing the application range and selectivity of a differential mobility spectrometry-mass spectrometry platform for metabolomics. Anal Bioanal Chem 410:2865-2877
Mariani, Laura H; Martini, Sebastian; Barisoni, Laura et al. (2018) Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Nephrol Dial Transplant 33:310-318
Verma, Rakesh; Venkatareddy, Madhusudan; Kalinowski, Anne et al. (2018) Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus. PLoS One 13:e0198013

Showing the most recent 10 out of 178 publications